Oxaliplatin
Showing 2551 - 2575 of 2,879
MDS, Acute Myeloid Leukemia, Leukemia Trial in Houston (Oxaliplatin, Fludarabine, Cytarabine)
Terminated
- Myelodysplastic Syndromes
- +2 more
- Oxaliplatin
- +2 more
-
Houston, TexasUT MD Anderson Cancer Center
Aug 1, 2012
Cancer of the Gallbladder, Cancer of the Biliary Tract Trial in Houston (Capecitabine, Oxaliplatin)
Completed
- Cancer of the Gallbladder
- Cancer of the Biliary Tract
- Capecitabine
- Oxaliplatin
-
Houston, TexasU.T. M.D. Anderson Cancer Center
Jul 27, 2012
Survival of Peritoneal Mesothelioma After Cytoreductive Surgery
Completed
- Peritoneal Mesotheliomas
- Cytoreductive surgery and HIPEC
-
Montréal, Quebec, CanadaMaisonneuve Rosemont Hospital
Mar 15, 2013
Liver Cancer, Advanced Solid Tumors Trial in Houston (Fluorouracil, Avastin, Leucovorin)
Completed
- Liver Cancer
- Advanced Solid Tumors
- Fluorouracil
- +3 more
-
Houston, TexasU.T.M.D. Anderson Cancer Center
Jul 26, 2012
Pancreatic Cancer Trial (ICT of oxapliplatin, irinotecan, leucovorin, and fluorouracil and CCRT, ICT of
Unknown status
- Pancreatic Cancer
- ICT of oxapliplatin, irinotecan, leucovorin, and fluorouracil and CCRT
- ICT of Gemcitabine,oxapliplatin, leucovorin, and fluorouracil + CCRT
- (no location specified)
May 27, 2013
Anal, Colon, and Rectal Cancers, Colorectal Tumors, Colon/Rectal Cancer Trial in Stanford (Vandetanib, Capecitabine,
Completed
- Anal, Colon, and Rectal Cancers
- +2 more
- Vandetanib
- +3 more
-
Stanford, CaliforniaStanford University School of Medicine
Jul 12, 2012
Refractory Aggressive Non-Hodgkin's Lymphoma, Relapsing Aggressive Non-Hodgkin's Lymphoma Trial (Rituximab, Gemcitabine,
Completed
- Refractory Aggressive Non-Hodgkin's Lymphoma
- Relapsing Aggressive Non-Hodgkin's Lymphoma
- Rituximab, Gemcitabine, Oxaliplatin
- (no location specified)
Jul 11, 2012
Unknown Primary Tumors Trial in Houston (Gemcitabine (Gemox), Oxaliplatin, Questionnaire)
Completed
- Unknown Primary Neoplasms
- Gemcitabine (Gemox)
- +2 more
-
Houston, TexasU.T. M.D. Anderson Cancer Center
Aug 1, 2012
Breast Cancer Trial in Worldwide (oxaliplatin)
Terminated
- Breast Cancer
- oxaliplatin
-
Vienna (Wien), Austria
- +9 more
Jul 23, 2012
Colorectal Liver Metastases Trial in Houston (5-Fluorouracil, Bevacizumab, Leucovorin)
Terminated
- Colorectal Liver Metastases
- 5-Fluorouracil
- +3 more
-
Houston, TexasU.T.M.D. Anderson Cancer Center
Jul 27, 2012
Colorectal Cancer Trial in Beijing (Oxaliplatin, Xeloda, Calcium folinate (CF))
Unknown status
- Colorectal Cancer
- Oxaliplatin
- +4 more
-
Beijing, ChinaCancer Institute&Hospital Chinese Academy of Medical Sciences
Sep 5, 2012
Gastrointestinal Cancer Trial in Xijing (S-1 plus oxaliplatin)
Unknown status
- Gastrointestinal Cancer
- S-1 plus oxaliplatin
-
Xijing, Shanxi, ChinaXijing hospital of the fourth military medical univercity
May 28, 2012
Liver Metastases, Colorectal Cancer Trial in Harbin, Shenyang (bevacizumab plus chemo)
Unknown status
- Liver Metastases
- Colorectal Cancer
- bevacizumab plus chemotherapy
-
Harbin, Heilongjiang, China
- +1 more
Jan 28, 2013
Colorectal Cancer Trial in San Antonio (oblimersen sodium, fluorouracil, leucovorin calcium)
Completed
- Colorectal Cancer
- oblimersen sodium
- +3 more
-
San Antonio, TexasSan Antonio Cancer Institute
Jul 3, 2012
Colorectal Cancer, KRAS Wildtype, After Resection of Liver Metastases Trial in Munich (Folic Acid, 5-FU, Oxaliplatin)
Unknown status
- Colorectal Cancer
- +2 more
- Folic Acid
- +3 more
-
Munich, GermanyLudwig-Maximilians - University of Munich
Jul 5, 2012
Advanced Biliary Cancer Trial in Villejuif (Gemox, Cetuximab)
Completed
- Advanced Biliary Cancer
- Gemox, Cetuximab
-
Villejuif, FranceInstitut Gustave Roussy
Jun 12, 2012
Enumeration of Circulating Tumor Cells in Rectal Cancer
Unknown status
- Rectal Cancer
- radiation therapy
- capecitabine (625mg/m2,bid,d1-5 qw)and oxaliplatin (85mg/m2 d1 qw)
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Aug 21, 2012
Colorectal Cancer Trial in Cleveland (bevacizumab, erlotinib HCl, fluorouracil)
Completed
- Colorectal Cancer
- bevacizumab
- +4 more
-
Cleveland, Ohio
- +2 more
Aug 31, 2012
Colorectal Cancer Trial in Switzerland (capecitabine and oxaliplatin + cetuximab, capecitabine and oxaliplatin)
Completed
- Colorectal Cancer
- capecitabine and oxaliplatin + cetuximab
- capecitabine and oxaliplatin
-
Aarau, Switzerland
- +17 more
Jun 4, 2012
Rectal Cancer, Gastric Cancer, Bone Marrow Toxicity Trial in Beijing (Bone Marrow-sparing Intensity-Modulated Radiotherapy)
Unknown status
- Rectal Cancer
- +3 more
- Bone Marrow-sparing Intensity-Modulated Radiotherapy
-
Beijing, Beijing, ChinaDepartment of Radiation Oncology, Cancer Institute and Hospital,
May 28, 2013
Gastric Adenocarcinoma Trial in Beijing (Oxaliplatin+S-1, Adjuvant Oxaliplatin/S-1(SOX))
Unknown status
- Gastric Adenocarcinoma
- Oxaliplatin+S-1
- Adjuvant Oxaliplatin/S-1(SOX)
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Apr 23, 2012
Colorectal Cancer Trial in United States (bevacizumab, fluorouracil, leucovorin)
Completed
- Colorectal Cancer
- bevacizumab
- +3 more
-
Little Rock, Arkansas
- +162 more
Jan 16, 2013